Sinografin is a brand name of diatrizoate/iodipamide, approved by the FDA in the following formulation(s):
SINOGRAFIN (diatrizoate meglumine; iodipamide meglumine - solution; intrauterine)
Manufacturer: BRACCO
Approved Prior to Jan 1, 1982
Strength(s): 52.7%;26.8% [RLD]
Has a generic version of Sinografin been approved?
No. There is currently no therapeutically equivalent version of Sinografin available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Sinografin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
There are no current U.S. patents associated with Sinografin.
No comments:
Post a Comment